132 related articles for article (PubMed ID: 15626371)
1. A biochemical and pharmacological examination of Rhamphiophis oxyrhynchus (Rufous beaked snake) venom.
Lumsden NG; Ventura S; Dauer R; Hodgson WC
Toxicon; 2005 Feb; 45(2):219-31. PubMed ID: 15626371
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation of a neurotoxin from the venom of Boiga dendrophila (mangrove catsnake).
Lumsden NG; Fry BG; Ventura S; Kini RM; Hodgson WC
Toxicon; 2005 Mar; 45(3):329-34. PubMed ID: 15683871
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of rufoxin, a novel protein exhibiting neurotoxicity from venom of the psammophiine, Rhamphiophis oxyrhynchus (Rufous beaked snake).
Lumsden NG; Banerjee Y; Kini RM; Kuruppu S; Hodgson WC
Neuropharmacology; 2007 Mar; 52(4):1065-70. PubMed ID: 17194464
[TBL] [Abstract][Full Text] [Related]
4. The in vitro and in vivo pharmacological activity of Boiga dendrophila (mangrove catsnake) venom.
Lumsden NG; Fry BG; Ventura S; Kini RM; Hodgson WC
Auton Autacoid Pharmacol; 2004 Oct; 24(4):107-13. PubMed ID: 15595930
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular action of venom from the South American colubrid snake Philodryas patagoniensis.
Carreiro da Costa RS; Prudêncio L; Ferrari EF; Souza GH; de Mello SM; Prianti Júnior AC; Ribeiro W; Zamunér SR; Hyslop S; Cogo JC
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jul; 148(1):31-8. PubMed ID: 18455482
[TBL] [Abstract][Full Text] [Related]
6. A survey on some biochemical and pharmacological activities of venom from two Colombian colubrid snakes, Erythrolamprus bizona (Double-banded coral snake mimic) and Pseudoboa neuwiedii (Neuwied's false boa).
Torres-Bonilla KA; Floriano RS; Schezaro-Ramos R; Rodrigues-Simioni L; da Cruz-Höfling MA
Toxicon; 2017 Jun; 131():29-36. PubMed ID: 28284847
[TBL] [Abstract][Full Text] [Related]
7. In vitro neuromuscular activity of 'colubrid' venoms: clinical and evolutionary implications.
Lumsden NG; Fry BG; Manjunatha Kini R; Hodgson WC
Toxicon; 2004 Jun; 43(7):819-27. PubMed ID: 15284016
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic neuromuscular activity of venom from the brown-headed snake (Glyphodon tristis).
Kuruppu S; Fry BG; Hodgson WC
Toxicon; 2005 Mar; 45(3):383-8. PubMed ID: 15683878
[TBL] [Abstract][Full Text] [Related]
9. Isolation and pharmacological characterisation of hostoxin-1, a postsynaptic neurotoxin from the venom of the Stephen's banded snake (Hoplocephalus stephensi).
Tan LC; Kuruppu S; Smith AI; Reeve S; Hodgson WC
Neuropharmacology; 2006 Sep; 51(4):782-8. PubMed ID: 16806296
[TBL] [Abstract][Full Text] [Related]
10. The effects of five phospholipases A2 from the venom of king brown snake, Pseudechis australis, on nerve and muscle.
Fatehi M; Rowan EG; Harvey AL; Harris JB
Toxicon; 1994 Dec; 32(12):1559-72. PubMed ID: 7725325
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation.
Ramasamy S; Isbister GK; Hodgson WC
Toxicon; 2004 Dec; 44(8):837-45. PubMed ID: 15530965
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the pharmacological activity of venom from the white-tailed spider (Lampona cylindrata).
Rash LD; King RG; Hodgson WC
Toxicon; 2000 Aug; 38(8):1111-27. PubMed ID: 10708802
[TBL] [Abstract][Full Text] [Related]
13. Biological activities of Leptodeira annulata (banded cat-eyed snake) venom on vertebrate neuromuscular preparations.
Torres-Bonilla KA; Schezaro-Ramos R; Floriano RS; Rodrigues-Simioni L; Bernal-Bautista MH; Alice da Cruz-Höfling M
Toxicon; 2016 Sep; 119():345-51. PubMed ID: 27390040
[TBL] [Abstract][Full Text] [Related]
14. In vitro neurotoxic and myotoxic effects of the venom from the black whip snake (Demansia papuensis).
Kuruppu S; Fry BG; Hodgson WC
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):364-8. PubMed ID: 16620302
[TBL] [Abstract][Full Text] [Related]
15. A pharmacological examination of venom from the Papuan taipan (Oxyuranus scutellatus canni).
Crachi MT; Hammer LW; Hodgson WC
Toxicon; 1999 Dec; 37(12):1721-34. PubMed ID: 10519650
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic activity of venom from the Australian eastern mouse spider (Missulena bradleyi) involves modulation of sodium channel gating.
Rash LD; Birinyi-Strachan LC; Nicholson GM; Hodgson WC
Br J Pharmacol; 2000 Aug; 130(8):1817-24. PubMed ID: 10952670
[TBL] [Abstract][Full Text] [Related]
17. A pharmacological examination of venoms from three species of death adder (Acanthophis antarcticus, Acanthophis praelongus and Acanthophis pyrrhus).
Wickramaratna JC; Hodgson WC
Toxicon; 2001; 39(2-3):209-16. PubMed ID: 10978738
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): efficacy of tiger snake antivenom.
Hodgson WC; Eriksson CO; Alewood PF; Fry BG
Clin Exp Pharmacol Physiol; 2003 Mar; 30(3):127-32. PubMed ID: 12603339
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent cardiovascular and neuromuscular effects of stonefish (Synanceja trachynis) venom.
Church JE; Hodgson WC
Toxicon; 2000 Mar; 38(3):391-407. PubMed ID: 10669028
[TBL] [Abstract][Full Text] [Related]
20. Species-dependent variations in the in vitro myotoxicity of death adder (Acanthophis) venoms.
Wickramaratna JC; Fry BG; Hodgson WC
Toxicol Sci; 2003 Aug; 74(2):352-60. PubMed ID: 12773755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
